Section 721.8153 - Di-substituted propanedione (generic)(a)Chemical substance and significant new uses subject to reporting.(1) The chemical substance identified generically as di-substituted propanedione (PMN P-97-94) is subject to reporting under this section for the significant new uses described in paragraph (a)(2) of this section.(2) The significant new uses are: (i)Protection in the workplace. Requirements as specified in § 721.63 (a)(1), (a)(2)(i), (a)(2)(ii), (a)(2)(iii), (a)(3), (b) (concentration set at 1.0 percent), and (c).(ii)Hazard communication program. Requirements as specified in § 721.72 (a), (b), (c), (d), (e) (concentration set at 1.0 percent), (f), (g)(2)(i), (g)(2)(v). The following statement shall appear on each label as specified in § 721.72(b) and the SDS as specified in § 721.72(c) : This substance is expected to be dermally absorbed and may cause effects to the liver, kidney, adrenal glands, and the heart.(iii)Industrial, commercial, and consumer activities. Requirements as specified in § 721.80(q) .(b)Specific requirements. The provisions of subpart A of this part apply to this section except as modified by this paragraph. (1)Recordkeeping. Recordkeeping requirements as specified in § 721.125 (a), (b), (c), (d), (e), (f), (g), (h), and (i) are applicable to manufacturers, importers, and processors of this substance.(2)Limitations or revocation of certain notification requirements. The provisions of § 721.185 apply to this section.(3)Determining whether a specific use is subject to this section. The provisions of § 721.1725(b)(1) apply to this section.